Hyster-Yale (HY) EBITDA (2011 - 2026)

Hyster-Yale has reported EBITDA for 16 years, with the latest figure at -$28.0 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 231.46% year-over-year to -$28.0 million; the trailing twelve-month figure through Mar 2026 stood at -$71.4 million (down 139.17% YoY), and the FY2025 full-year result was -$22.1 million, down 109.03% from the prior year.
• EBITDA for Q1 2026 stood at -$28.0 million, up from -$37.2 million in the prior quarter.
• The five-year high for EBITDA was $95.6 million in Q2 2024, with the low at -$37.2 million in Q4 2025.
• Historically, EBITDA has averaged $21.4 million across 5 years, with a median of $21.3 million in 2025.
• Annual changes were most pronounced in 2022 — EBITDA slumped 690.32% — and 2023, when it surged 474.52%.
• Hyster-Yale's EBITDA stood at $19.8 million in 2022, then soared by 145.96% to $48.7 million in 2023, then tumbled by 33.68% to $32.3 million in 2024, then plunged by 215.17% to -$37.2 million in 2025, then climbed by 24.73% to -$28.0 million in 2026.
• The last three EBITDA figures came in at -$28.0 million (Q1 2026), -$37.2 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.